Cargando…

Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases

Proton pump inhibitors (PPIs) have been associated with decreased gut microbiota diversity. Disrupted gut microbiota composition has been reported in several autoimmune diseases (ADs), such as type 1 diabetes mellitus (DM), autoimmune thyroiditis (AIT), juvenile idiopathic arthritis (JIA), and infla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Räisänen, Laura, Viljakainen, Heli, Kolho, Kaija-Leena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083351/ https://www.ncbi.nlm.nih.gov/pubmed/37051434 http://dx.doi.org/10.3389/fped.2023.1157547

Ejemplares similares

Antibiotic exposures and the development of pediatric autoimmune diseases: a register-based case–control study
por: Räisänen, Laura K., et al.
Publicado: (2022)

Perinatal risk factors for pediatric onset type 1 diabetes, autoimmune thyroiditis, juvenile idiopathic arthritis, and inflammatory bowel diseases
por: Räisänen, Laura, et al.
Publicado: (2021)

Central obesity in school‐aged children increases the likelihood of developing paediatric autoimmune diseases
por: Räisänen, Laura, et al.
Publicado: (2021)

Pre-Diagnostic Saliva Microbiota of School-Aged Children Who Developed Type 1 Diabetes or Inflammatory Bowel Diseases
por: Räisänen, Laura, et al.
Publicado: (2023)

Therapeutic Drug Monitoring and Outcome of Infliximab Therapy in Pediatric Onset Inflammatory Bowel Disease
por: Kolho, Kaija-Leena
Publicado: (2021)

Sex- and weight-specific changes in the frequency of sweet treat consumption during early adolescence: a longitudinal study
por: Lommi, Sohvi, et al.
Publicado: (2021)

The Role of Proton Pump Inhibitors in the Management of Pediatric Eosinophilic Esophagitis
por: Gutiérrez-Junquera, Carolina, et al.
Publicado: (2018)

Fecal Calprotectin and Clinical Disease Activity in Pediatric Ulcerative Colitis
por: Kolho, Kaija-Leena, et al.
Publicado: (2013)

The Composition and Functional Capacities of Saliva Microbiota Differ Between Children With Low and High Sweet Treat Consumption
por: Lommi, Sohvi, et al.
Publicado: (2022)

Clustering of pediatric onset inflammatory bowel disease in Finland: a nationwide register-based study
por: Nikkilä, Atte, et al.
Publicado: (2022)

Trends in Early Outpatient Drug Therapy in Pediatric Inflammatory Bowel Disease in Finland: A Nationwide Register-Based Study in 1999–2009
por: Virta, Lauri J., et al.
Publicado: (2012)

Use of proton pump inhibitors in scandinavian children and adolescents: An observational study
por: Closs, Emilie Raaum, et al.
Publicado: (2023)

Non-Specific Gastric Inflammation in Children is Associated with Proton Pump Inhibitor Treatment for More than 6 Weeks
por: Rosas-Blum, Eduardo, et al.
Publicado: (2014)

Screening for adrenal suppression in children with inflammatory bowel disease discontinuing glucocorticoid therapy
por: Sidoroff, Marianne, et al.
Publicado: (2014)

Serum and Urinary Osteocalcin in Healthy 7- to 19-Year-Old Finnish Children and Adolescents
por: Paldánius, Päivi M., et al.
Publicado: (2021)

GNAS, PDE4D, and PRKAR1A Mutations and GNAS Methylation Changes Are Not a Common Cause of Isolated Early-Onset Severe Obesity Among Finnish Children
por: Loid, Petra, et al.
Publicado: (2020)

Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis
por: Nousiainen, Pauliina, et al.
Publicado: (2014)

Sleep and Emotional and Behavioral Symptoms in Adolescents with Inflammatory Bowel Disease
por: Pirinen, Teija, et al.
Publicado: (2014)

Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use
por: Aalto, Kristiina, et al.
Publicado: (2017)

Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study
por: Lin, Sheng-Hong, et al.
Publicado: (2021)

The Impact of Proton Pump Inhibitors on the Development of Gastric Neoplastic Lesions in Patients With Autoimmune Atrophic Gastritis
por: Dilaghi, Emanuele, et al.
Publicado: (2022)

Autoimmune Cytopenias in Pediatric Hematopoietic Cell Transplant Patients
por: Neely, Jessica A., et al.
Publicado: (2019)

HLA-DQ and HLA-DRB1 alleles associated with Henoch-Schönlein purpura nephritis in Finnish pediatric population: a genome-wide association study
por: Koskela, Mikael, et al.
Publicado: (2021)

Clinical Features and Outcomes in Pediatric Autoimmune Encephalitis Associated With CASPR2 Antibody
por: Tan, Chengbing, et al.
Publicado: (2021)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Lactose inhibits regulatory T-cell-mediated suppression of effector T-cell interferon-γ and IL-17 production
por: Paasela, Monika, et al.
Publicado: (2014)

The Covert Surge: Murine Bile Acid Levels Are Associated With Pruritus in Pediatric Autoimmune Sclerosing Cholangitis
por: Meinel, Katharina, et al.
Publicado: (2022)

Autoimmune Gastritis in the Pediatric Age: An Underestimated Condition Report of Two Cases and Review
por: Saglietti, Chiara, et al.
Publicado: (2018)

Rapidly Progressing Autoimmune Hemolytic Anemia in a Pediatric Patient With COVID-19
por: Kononowicz, Julia E, et al.
Publicado: (2023)

Proton Pump Inhibitors in Pediatrics: Mechanism of Action, Pharmacokinetics, Pharmacogenetics, and Pharmacodynamics
por: Ward, Robert M., et al.
Publicado: (2013)

Proton pump inhibitors are associated with increased risk of development of chronic kidney disease
por: Arora, Pradeep, et al.
Publicado: (2016)

The gut fungal and bacterial microbiota in pediatric patients with inflammatory bowel disease introduced to treatment with anti-tumor necrosis factor-α
por: Ventin-Holmberg, Rebecka, et al.
Publicado: (2022)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Diagnostic Approach to Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (PANDAS): A Narrative Review of Literature Data
por: Prato, Adriana, et al.
Publicado: (2021)

Association between proton pump inhibitors and periodontal disease severity
por: Chawla, Bhavneet K., et al.
Publicado: (2021)

Is hypomagnesemia associated with using proton pump inhibitors?
por: Yi, Joo-Hark, et al.
Publicado: (2016)

Proton Pump Inhibitor-associated Mucosal Change
por: Kato, Mototsugu, et al.
Publicado: (2017)

Problems Associated with Deprescribing of Proton Pump Inhibitors
por: Helgadottir, Holmfridur, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_029ocdd3r1c2n7hnp561kpk9i4